J&J gets flamed over the weekend with a social media firestorm over a Motrin ad. Here’s the backstory, with more here. Frankly, I think this constitutes an over-reaction, and may discourage other healthcare companies from putting their toe in the social media water. On the positive side, it certainly demonstrates the enormous potential and viral nature of social media (for good or for ill!)
Centocor launches interactive website for patient-doctor interactions about Remicade.
Will the drug business lose the right to advertise?
InVentiv Communications agencies score big at annual MM&M awards.
Nielsen white paper on how pharma can use social media (free download).
Leave a Reply